COVID-19 has resulted in delayed care across specialties. Join us as we discuss returning to pre-pandemic clinical activity and strategies that biopharma organizations are using to engage HCPs

The session will review: Historical Immunization trends and how this compares to COVID-19 vaccinations Current data to assess COVID-19 case counts and vaccine accessibility Which specialties are trending upward towards pre-pandemic clinical activity, and which are not Strategies that biotechnology and pharmaceutical companies are using to engage with HCPs in these uncertain times